​​A voluntary research study is currently being conducted to evaluate different medications that treat relapsing remitting forms of multiple sclerosis (MS).

​

You may qualify to participate in this voluntary research study if you:

  ♦​ are between the ages of 18 and 65

  ♦ have been diagnosed with a relapsing remitting form of MS

​  ♦ are naive to treatment; or have 5 years or less of total lifetime exposure

     to one class of Disease Modifying Therapy (DMT)

​

Qualified participants will receive study-related exams and study medication ay no cost.

Are You Currently Being Treated for a Relapsing Remitting Form of Multiple Sclerosis?